Transmission
14
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
21%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Couples and Microbial Diversity
Baby 2 Baby Beneficial Bacteria
Transmission of Oncogenic HPV Infection Among Families
Transmission Of Respiratory Tract microOrganisms In a School Environment
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement
Epidemiology of Helicobacter Pylori Infection in Children From Slovenia
An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission
Persistence of Zika Virus in Semen After Acute Infection
Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
Controlled Human Malaria Infection Model for Evaluation of Transmission-blocking Interventions - Study 2
Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort
Mother-to-child Hepatitis D Transmission
Vertical Transmission of Hepatitis C Virus
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B